233 related articles for article (PubMed ID: 12846808)
1. The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease.
O'Connor BP; Gleeson MW; Noelle RJ; Erickson LD
Immunol Rev; 2003 Aug; 194():61-76. PubMed ID: 12846808
[TBL] [Abstract][Full Text] [Related]
2. Temporal dynamics and genomic programming of plasma cell fates.
Vijay GKM; Zhou M; Thakkar K; Rothrauff A; Chawla AS; Chen D; Lau LC; Habib P; Chetal K; Chhibbar P; Fan J; Das J; Joglekar A; Borghesi L; Salomonis N; Xu H; Singh H
Res Sq; 2023 Sep; ():. PubMed ID: 37720050
[TBL] [Abstract][Full Text] [Related]
3. Insights into the relationship between persistent antibody secretion and metabolic programming - A question for single-cell analysis.
Bucheli OTM; Eyer K
Immunol Lett; 2023 Aug; 260():35-43. PubMed ID: 37315849
[TBL] [Abstract][Full Text] [Related]
4. Temporal Tracking of Plasma Cells
Borbet TC; Zaldaña K; Zavitsanou AM; Hines MJ; Bajwa S; Morrison T; Boehringer T; Hallisey VM; Cadwell K; Koralov SB
bioRxiv; 2023 Dec; ():. PubMed ID: 38106171
[TBL] [Abstract][Full Text] [Related]
5. Affinity alone does not drive long-lived plasma cell differentiation.
McDougal CE; Pepper M
Immunol Cell Biol; 2024 May; ():. PubMed ID: 38715314
[TBL] [Abstract][Full Text] [Related]
6. Predicting plasma cell retention and loss over a lifetime.
Robinson MJ; Tarlinton DM
Immunity; 2024 Mar; 57(3):408-410. PubMed ID: 38479357
[TBL] [Abstract][Full Text] [Related]
7. Zinc Oxide Nanoparticles Trigger Autophagy in the Human Multiple Myeloma Cell Line RPMI8226: an In Vitro Study.
Li Z; Yin X; Lyu C; Wang J; Liu K; Cui S; Ding S; Wang Y; Wang J; Guo D; Xu R
Biol Trace Elem Res; 2024 Mar; 202(3):913-926. PubMed ID: 37432567
[TBL] [Abstract][Full Text] [Related]
8. Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications.
Chen M; Jiang J; Hou J
Biomark Res; 2023 May; 11(1):55. PubMed ID: 37259170
[TBL] [Abstract][Full Text] [Related]
9. Adoptive Immunotherapy and High-Risk Myeloma.
Duane C; O'Dwyer M; Glavey S
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174099
[TBL] [Abstract][Full Text] [Related]
10. GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma.
Ni L; Chen S; Liu J; Li H; Zhao H; Zheng C; Zhang Y; Huang H; Huang J; Wang B; Lin C
Mediators Inflamm; 2023; 2023():7123568. PubMed ID: 37124060
[TBL] [Abstract][Full Text] [Related]
11. Immune dysregulation in multiple myeloma: the current and future role of cell-based immunotherapy.
Russell BM; Avigan DE
Int J Hematol; 2023 May; 117(5):652-659. PubMed ID: 36964840
[TBL] [Abstract][Full Text] [Related]
12. Structural and Ultrastructural Analysis of the Multiple Myeloma Cell Niche and a Patient-Specific Model of Plasma Cell Dysfunction.
Harmon KA; Roman S; Lancaster HD; Chowhury S; Cull E; Goodwin RL; Arce S; Fanning S
Microsc Microanal; 2022 Feb; 28(1):254-264. PubMed ID: 34881690
[TBL] [Abstract][Full Text] [Related]
13. Cancer immunoediting and immune dysregulation in multiple myeloma.
Nakamura K; Smyth MJ; Martinet L
Blood; 2020 Dec; 136(24):2731-2740. PubMed ID: 32645135
[TBL] [Abstract][Full Text] [Related]
14. Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1.
Tai YT; Cho SF; Anderson KC
Front Immunol; 2018; 9():1822. PubMed ID: 30147691
[TBL] [Abstract][Full Text] [Related]
15. CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma.
Yousef S; Kovacsovics-Bankowski M; Salama ME; Bhardwaj N; Steinbach M; Langemo A; Kovacsovics T; Marvin J; Binder M; Panse J; Kröger N; Luetkens T; Atanackovic D
Hum Vaccin Immunother; 2015; 11(7):1606-11. PubMed ID: 26001047
[TBL] [Abstract][Full Text] [Related]
16. Inside-out assembly of viral antigens for the enhanced vaccination.
Cao F; Peng S; An Y; Xu K; Zheng T; Dai L; Ogino K; Ngai T; Xia Y; Ma G
Signal Transduct Target Ther; 2023 May; 8(1):189. PubMed ID: 37221173
[TBL] [Abstract][Full Text] [Related]
17. Autophagy and Its Lineage-Specific Roles in the Hematopoietic System.
Hasan KMM; Haque MA
Oxid Med Cell Longev; 2023; 2023():8257217. PubMed ID: 37180758
[TBL] [Abstract][Full Text] [Related]
18. An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19.
Soleimanian S; Alyasin S; Sepahi N; Ghahramani Z; Kanannejad Z; Yaghobi R; Karimi MH
Front Immunol; 2022; 13():884879. PubMed ID: 35669767
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Interleukin-33 in Recombinant Rabies Virus Enhances Innate and Humoral Immune Responses through Activation of Dendritic Cell-Germinal Center Reactions.
Mi Z; Zhao L; Sun M; Gao T; Wang Y; Sui B; Li Y
Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062695
[TBL] [Abstract][Full Text] [Related]
20. Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics.
Kumar V
Int Immunopharmacol; 2020 Nov; 88():106980. PubMed ID: 33182073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
